1 |
Crea F, Hurt EM, Mathews LA et al (2011) Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer. Mol Cancer 10, 40
DOI
|
2 |
Benoit YD, Witherspoon MS, Laursen KB et al (2013) Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells. Exp Cell Res 319, 1463-1470
DOI
|
3 |
Yang J, Chai L, Liu F et al (2007) Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Nat Acad Sci U S A 104, 10494-10499
DOI
|
4 |
Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J and Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29, 8884-8896
DOI
|
5 |
Pathania R, Ramachandran S, Elangovan S et al (2015) DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis. Nat Commun 6, 6910
DOI
|
6 |
Yang L, Rau R and Goodell MA (2015) DNMT3A in haematological malignancies. Nat Rev Cancer 15, 152-165
DOI
|
7 |
Heddleston JM, Wu Q, Rivera M et al (2012) Hypoxiainduced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential. Cell Death Differ 19, 428-439
DOI
|
8 |
Bonnet D and Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-737
DOI
|
9 |
Chaffer CL, Marjanovic ND, Lee T et al (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74
DOI
|
10 |
Roesch A, Fukunaga-Kalabis M, Schmidt EC et al (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141, 583-594
DOI
|
11 |
Frank NY, Schatton T and Frank MH (2010) The therapeutic promise of the cancer stem cell concept. J Clin Invest 120, 41-50
DOI
|
12 |
Bao S, Wu Q, McLendon RE et al (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760
DOI
|
13 |
Lapidot T, Sirard C, Vormoor J et al (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648
DOI
|
14 |
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100, 3983-3988
DOI
|
15 |
Medema JP (2013) Cancer stem cells: The challenges ahead. Nat Cell Biol 15, 338-344
DOI
|
16 |
Jeon HM, Sohn YW, Oh SY et al (2011) ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res 71, 3410-3421
DOI
|
17 |
Brooks MD, Burness ML and Wicha MS (2015) Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer. Cell Stem Cell 17, 260-271
DOI
|
18 |
Sun Y, Campisi J, Higano C et al (2012) Treatmentinduced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 18, 1359-1368
DOI
|
19 |
Plaks V, Kong N and Werb Z (2015) The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell 16, 225-238
DOI
|
20 |
Ricci-Vitiani L, Pallini R, Biffoni M et al (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828
DOI
|
21 |
Cheng L, Huang Z, Zhou W et al (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153, 139-152
DOI
|
22 |
Justilien V and Fields AP (2015) Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells. Clin Cancer Res 21, 505-513
DOI
|
23 |
Schmohl JU and Vallera DA (2016) CD133, Selectively Targeting the Root of Cancer. Toxins (Basel) 8, 165
DOI
|
24 |
Gurney A, Axelrod F, Bond CJ et al (2012) Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci U S A 109, 11717-11722
DOI
|
25 |
Gavai AV, Quesnelle C, Norris D et al (2015) Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors. ACS Med Chem Lett 6, 523-527
DOI
|
26 |
Huang SD, Yuan Y, Tang H et al (2013) Tumor cells positive and negative for the common cancer stem cell markers are capable of initiating tumor growth and generating both progenies. PLoS One 8, e54579
DOI
|
27 |
Kim J, Villadsen R, Sorlie T et al (2012) Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci U S A 109, 6124-6129
DOI
|
28 |
Patel AP, Tirosh I, Trombetta JJ et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396-1401
DOI
|
29 |
Liu S, Cong Y, Wang D et al (2014) Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports 2, 78-91
DOI
|
30 |
Meyer M, Reimand J, Lan X et al (2015) Single cellderived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proc Natl Acad Sci U S A 112, 851-856
DOI
|
31 |
Brennan CW, Verhaak RG, McKenna A et al (2013) The somatic genomic landscape of glioblastoma. Cell 155, 462-477
DOI
|
32 |
Mao P, Joshi K, Li J et al (2013) Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A 110, 8644-8649
DOI
|
33 |
Bhat KP, Balasubramaniyan V, Vaillant B et al (2013) Mesenchymal differentiation mediated by NF-kappaB promotes radiation resistance in glioblastoma. Cancer Cell 24, 331-346
DOI
|
34 |
Das R, Gregory PA, Hollier BG, Tilley WD and Selth LA (2014) Epithelial plasticity in prostate cancer: principles and clinical perspectives. Trends Mol Med 20, 643-651
DOI
|
35 |
Banyard J, Chung I, Wilson AM et al (2013) Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Sci Rep 3, 3151
DOI
|
36 |
Ruscetti M, Dadashian EL, Guo W et al (2016) HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene 35, 3781-3795
DOI
|
37 |
Ebrahimi B (2015) Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency. Cell Regen (Lond) 4, 10
|
38 |
Charafe-Jauffret E, Ginestier C, Iovino F et al (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69, 1302-1313
DOI
|
39 |
Petersen OW, Nielsen HL, Gudjonsson T et al (2003) Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma. Am J Pathol 162, 391-402
DOI
|
40 |
Hanahan D and Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
DOI
|
41 |
Jiao X, Katiyar S, Willmarth NE et al (2010) c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion. J Biol Chem 285, 8218-8226
DOI
|
42 |
Xin YH, Bian BS, Yang XJ et al (2013) POU5F1 enhances the invasiveness of cancer stem-like cells in lung adenocarcinoma by upregulation of MMP-2 expression. PLoS One 8, e83373
DOI
|
43 |
Chen L, Fan J, Chen H et al (2014) The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. Sci Rep 4, 5911
|
44 |
Friedl P and Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147, 992-1009
DOI
|
45 |
Eppert K, Takenaka K, Lechman ER et al (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17, 1086-1093
DOI
|
46 |
Piccirillo SG, Colman S, Potter NE et al (2015) Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports 4, 7-15
DOI
|
47 |
Meacham CE and Morrison SJ (2013) Tumour heterogeneity and cancer cell plasticity. Nature 501, 328-337
DOI
|
48 |
Yan G-N, Yang L, Lv Y-F et al (2014) Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. J Pathol 234, 11-22
DOI
|
49 |
Chen K, Huang Y-h and Chen J-l (2013) Understanding and targeting cancer stem cells: therapeutic implications and challenges. Acta Pharmacol Sin 34, 732-740
DOI
|
50 |
Sirko S, Behrendt G, Johansson PA et al (2013) Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. Cell Stem Cell 12, 426-439
DOI
|
51 |
Hay ED (1995) An overview of epithelial-mesenchymal transformation. Acta Anat (Basel) 154, 8-20
DOI
|
52 |
Mani SA, Guo W, Liao MJ et al (2008) The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715
DOI
|
53 |
Ouyang G, Wang Z, Fang X, Liu J and Yang CJ (2010) Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci 67, 2605-2618
DOI
|
54 |
Karin M and Greten FR (2005) NF-kappa B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749-759
DOI
|
55 |
Li CW, Xia W, Huo L et al (2012) Epithelial-mesenchymal transition induced by TNF-alpha requires NF-kappaB-mediated transcriptional upregulation of Twist1. Cancer Res 72, 1290-1300
DOI
|
56 |
Li Y, Li A, Glas M et al (2011) c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci U S A 108, 9951-9956
DOI
|
57 |
Jeter CR, Liu B, Liu X et al (2011) NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 30, 3833-3845
DOI
|
58 |
Takahashi K and Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676
DOI
|
59 |
Suva ML, Rheinbay E, Gillespie SM et al (2014) Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell 157, 580-594
DOI
|
60 |
Lee TK, Castilho A, Cheung VC, Tang KH, Ma S and Ng IO (2011) CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell 9, 50-63
DOI
|
61 |
Rudin CM, Durinck S, Stawiski EW et al (2012) Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 44, 1111-1116
DOI
|
62 |
Suva ML, Rheinbay E, Gillespie SM et al (2014) Reconstructing and reprogramming the tumor propagating potential of glioblastoma stem-like cells. Cell 157, 580-594
DOI
|
63 |
Li L and Xie T (2005) Stem cell niche: structure and function. Annu Rev Cell Dev Biol 21, 605-631
DOI
|
64 |
Plaks V, Kong N and Werb Z (2015) The Cancer Stem Cell Niche: How Essential is the Niche in Regulating Stemness of Tumor Cells? Cell stem cell 16, 225-238
DOI
|
65 |
Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C and Morrison SJ (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121
DOI
|
66 |
Oh M and Nor JE (2015) The Perivascular Niche and Self-Renewal of Stem Cells. Front Physiol 6, 367
|
67 |
Yan GN, Yang L, Lv YF et al (2014) Endothelial cells promote stem-like phenotype of glioma cells through activating the Hedgehog pathway. J Pathol 234, 11-22
DOI
|
68 |
Calabrese C, Poppleton H, Kocak M et al (2007) A Perivascular Niche for Brain Tumor Stem Cells. Cancer Cell 11, 69-82
DOI
|
69 |
Charles N, Ozawa T, Squatrito M et al (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6, 141-152
DOI
|
70 |
Jeon HM, Kim SH, Jin X et al (2014) Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression. Cancer Res 74, 4482-4492
DOI
|
71 |
Jogi A, Ora I, Nilsson H et al (2002) Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A 99, 7021-7026
DOI
|
72 |
Beck B, Driessens G, Goossens S et al (2011) A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 478, 399-403
DOI
|
73 |
Zhang Z, Dong Z, Lauxen IS, Filho MS and Nor JE (2014) Endothelial cell-secreted EGF induces epithelial to mesenchymal transition and endows head and neck cancer cells with stem-like phenotype. Cancer Res 74, 2869-2881
DOI
|
74 |
Simon MC and Keith B (2008) The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 9, 285-296
DOI
|
75 |
Lofstedt T, Jogi A, Sigvardsson M et al (2004) Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 279, 39223-39231
DOI
|
76 |
Bao B, Azmi AS, Ali S et al (2012) The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochimica et biophysica acta 1826, 272-296
|
77 |
Zhang C, Samanta D, Lu H et al (2016) Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Nat Acad Sci U S A 113, E2047-E2056
DOI
|
78 |
Yang MH, Wu MZ, Chiou SH et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10, 295-305
DOI
|
79 |
Joseph JV, Conroy S, Pavlov K et al (2015) Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1alpha-ZEB1 axis. Cancer Lett 359, 107-116
DOI
|
80 |
Xing F, Okuda H, Watabe M et al (2011) Hypoxiainduced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene 30, 4075-4086
DOI
|
81 |
Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ and Feng YM (2014) Cancer-associated fibroblasts induce epithelialmesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br J Cancer 110, 724-732
DOI
|
82 |
Condeelis J and Pollard JW (2006) Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis. Cell 124, 263-266
DOI
|
83 |
Sullivan NJ, Sasser AK, Axel AE et al (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28, 2940-2947
DOI
|
84 |
Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM and Zhou BP (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15, 416-428
DOI
|
85 |
Orkin SH and Hochedlinger K (2011) Chromatin connections to pluripotency and cellular reprogramming. Cell 145, 835-850
DOI
|
86 |
Vermeulen L, De Sousa E Melo F, van der Heijden M et al (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12, 468-476
DOI
|
87 |
Hamada S, Masamune A, Takikawa T et al (2012) Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Biochem Biophys Res Commun 421, 349-354
DOI
|
88 |
Lotti F, Jarrar AM, Pai RK et al (2013) Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. J Exp Med 210, 2851-2872
DOI
|
89 |
Liang G and Zhang Y (2013) Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Cell Res 23, 49-69
DOI
|
90 |
Widschwendter M, Fiegl H, Egle D et al (2007) Epigenetic stem cell signature in cancer. Nat Genet 39, 157-158
DOI
|
91 |
Ohm JE, McGarvey KM, Yu X et al (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39, 237-242
DOI
|
92 |
Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN and Struhl K (2010) Loss of miR-200 inhibition of Suz12 leads to Polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 39, 761-772
DOI
|
93 |
Kreso A and Dick JE (2014) Evolution of the cancer stem cell model. Cell Stem Cell 14, 275-291
DOI
|
94 |
Easwaran H, Johnstone SE, Van Neste L et al (2012) A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res 22, 837-849
DOI
|
95 |
Rizzo S, Hersey JM, Mellor P et al (2011) Ovarian cancer stem cell-like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther 10, 325-335
DOI
|